“The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12”.Genomics21(2): 403–8.(May 1994).doi:10.1006/geno.1994.1283.PMID7916328.
“Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3”.FEBS Letters395(2–3): 277–82.(October 1996).doi:10.1016/0014-5793(96)01024-1.PMID8898111.
“Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy”.Biochemistry36(15): 4412–22.(April 1997).doi:10.1021/bi9627929.PMID9109648.
“Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity”.European Journal of Immunology29(2): 678–85.(February 1999).doi:10.1002/(SICI)1521-4141(199902)29:02<678::AID-IMMU678>3.0.CO;2-J.PMID10064085.
“A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation”.Journal of Immunology175(2): 1257–66.(July 2005).doi:10.4049/jimmunol.175.2.1257.PMID16002730.
“Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor”.Journal of Immunology161(1): 342–6.(July 1998).doi:10.4049/jimmunol.161.1.342.PMID9647242.
“Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines”.Biochemical and Biophysical Research Communications191(2): 535–42.(March 1993).doi:10.1006/bbrc.1993.1251.PMID8461011.
“CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin”.Experimental Dermatology24(7): 522–8.(July 2015).doi:10.1111/exd.12709.PMID25828150.
“The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12”.Genomics21(2): 403–8.(May 1994).doi:10.1006/geno.1994.1283.PMID7916328.
“Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3”.FEBS Letters395(2–3): 277–82.(October 1996).doi:10.1016/0014-5793(96)01024-1.PMID8898111.
“Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy”.Biochemistry36(15): 4412–22.(April 1997).doi:10.1021/bi9627929.PMID9109648.
“Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity”.European Journal of Immunology29(2): 678–85.(February 1999).doi:10.1002/(SICI)1521-4141(199902)29:02<678::AID-IMMU678>3.0.CO;2-J.PMID10064085.
“A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation”.Journal of Immunology175(2): 1257–66.(July 2005).doi:10.4049/jimmunol.175.2.1257.PMID16002730.
“Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor”.Journal of Immunology161(1): 342–6.(July 1998).doi:10.4049/jimmunol.161.1.342.PMID9647242.
“Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines”.Biochemical and Biophysical Research Communications191(2): 535–42.(March 1993).doi:10.1006/bbrc.1993.1251.PMID8461011.
“CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin”.Experimental Dermatology24(7): 522–8.(July 2015).doi:10.1111/exd.12709.PMID25828150.